期刊文献+

115例股静脉临时导管停用原因分析 被引量:1

Analysis on the causes necessitating removal of the temporary femoral vein catheters in 115 cases
下载PDF
导出
摘要 目的:探讨股静脉临时导管在初次血液透析患者中使用的临床意义及影响其使用的相关因素。方法:选取皖南医学院第一附属医院血液净化中心2014年2~6月使用股静脉临时导管进行血液透析的新入的CKD5期患者115例。对上述115例患者进行随访。记录透析前血清白蛋白、血红蛋白及血肌酐值,并记录静脉导管置入时间、停用时间及停用原因。依据停用原因分为常规停用组(内瘘启用)及非常规停用组(非内瘘启用)。结果:常规停用组与非常规停用组在男女比例、年龄大小及原发病方面无明显差异(P〉0.05)。常规停用组开始血液透析时的血红蛋白及血清白蛋白值均高于非常规停用组(P〈0.01);虽然常规停用组开始透析时血肌酐平均值低于非常规停用组,但无统计学意义(P〉0.05)。结论:绝大多数股静脉临时导管可以正常使用到内瘘成熟启用后拔出。患者的营养状况可能对其静脉导管的使用寿命有影响。 Objective:To investigate the clinical significance of temporary femoral venous access device in patients undergoing initial hemodialysis and re- lated factors necessitating removal of the cannulation. Methods :115 patients with chronic kidney disease (CKD) at stage 5 undergoing initial hemedialysis in our hospital during February and Jane of 2014 were included, and allocated to planned device removal group( fistula enabling dialysis) and non-planned device removal group ( non - fistula enabling dialysis). All patients were followed up and maintained regarding the levels of serum albumin, hemoglobin and serum creatinine before dialysis, the time of venous catheter placement and catheter removal as well as causes for necessary removal of the access device. Results : The two groups were not significant with regard to the ratio of genders, ages and presence of primary disease ( P 〉 0.05 ). However, the planned de- vice removal group had higher levels of hemoglobin and serum albumin upon dialysis (P 〈 0.01 ), and the serum creatinine level remained no significance between the two groups ( P 〉 0.05 ). Conclusion : Most femoral venous access device can be removed till maturing of permanent fistula, yet nutritional status of patients niay affect the service life of the catheter.
出处 《皖南医学院学报》 CAS 2015年第5期452-454,共3页 Journal of Wannan Medical College
关键词 股静脉临时导管 血液透析 血管通路 temporary femoral vein catheter hemodialysis vascular access
  • 相关文献

参考文献8

二级参考文献42

  • 1Besarab,A.,Access monitoring is worthwhile and valuable[J].Blood Purif,2006,24:77-89.
  • 2Rayner HC,Besarab A,Brown WW,et al.Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS):performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines[J].Am J Kidney Dis,2004,44(5 Suppl 2):22-26.
  • 3Teruel JL,Torrente J,Fernandez Lucas M,et al,[Evaluating renal function and indications for starting dialysis] [J].Nephrology,2009,29 Suppl 1:38-43.
  • 4Bradbury BD,Chen F,Furniss A,et al,Conversion of vascular access type among incident hemodialysis patients:description and association with mortality[J].Am J Kidney Dis,2009,53:804-814.
  • 5Goldstein,SL,Ikizler TA,Zappitelli M,et al.,Non-infected hemodialysis catheters are associated with increased inflammation compared to arteriovenous fistulas[J].Kidney Int,2009,76:1063-1069.
  • 6Clinical practice guidelines for vascular access[J].Am J Kidney Dis,2006,48 Suppl 1:S248-723.
  • 7Rodriguez Hernandez JA,Gonzalez Parra E,Julian Gutierrez JM,et al.Vascular access guidelines for hemodialysis[J].Nephrology,2005,25 Suppl 1:3-97.
  • 8Tattersall,J.,Dialysis in the over-80s[J].Age Ageing,2005,34:100-101.
  • 9Vascular Access 2006 Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis, 2006, 48 :S176-273.
  • 10Lomonte C, Basile C. Management of central venous catheter: prevention of thrombosis and bacteremia. G Ital Nefrol, 2009, 26: 73-80.

共引文献637

同被引文献17

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部